Bonesupport Holding AB (publ) (BONEX.ST)

SEK 382.8

(2.03%)

Operating Expenses Summary of Bonesupport Holding AB (publ)

Bonesupport Holding AB (publ)'s latest annual operating expenses in 2023 was 510.93 Million SEK , up 39.86% from previous year.
Bonesupport Holding AB (publ)'s latest quarterly operating expenses in 2024 Q2 was 173.08 Million SEK , up 24.96% from previous quarter.
Bonesupport Holding AB (publ) reported a annual operating expenses of 365.31 Million SEK in annual operating expenses 2022, up 33.19% from previous year.
Bonesupport Holding AB (publ) reported a annual operating expenses of 274.27 Million SEK in annual operating expenses 2021, up 6.39% from previous year.
Bonesupport Holding AB (publ) reported a quarterly operating expenses of 138.5 Million SEK for 2024 Q1, down -10.57% from previous quarter.
Bonesupport Holding AB (publ) reported a quarterly operating expenses of 173.08 Million SEK for 2024 Q2, up 24.96% from previous quarter.

Annual Operating Expenses Chart of Bonesupport Holding AB (publ) (2023 - 2014)

Historical Annual Operating Expenses of Bonesupport Holding AB (publ) (2023 - 2014)

Year	Operating Expenses	Operating Expenses Growth
2023	510.93 Million SEK	39.86%
2022	365.31 Million SEK	33.19%
2021	274.27 Million SEK	6.39%
2020	257.79 Million SEK	-12.19%
2019	293.59 Million SEK	14.25%
2018	256.98 Million SEK	22.42%
2017	209.91 Million SEK	17.88%
2016	178.07 Million SEK	67.11%
2015	106.56 Million SEK	37.23%
2014	77.65 Million SEK	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q3	179.66 Million SEK	3.81%
2024 Q1	138.5 Million SEK	-10.57%
2024 Q2	173.08 Million SEK	24.96%
2023 Q2	122.25 Million SEK	13.65%
2023 Q4	154.88 Million SEK	18.31%
2023 FY	510.93 Million SEK	39.86%
2023 Q1	107.56 Million SEK	-7.87%
2023 Q3	130.91 Million SEK	7.09%
2022 Q3	90.76 Million SEK	11.66%
2022 Q4	116.76 Million SEK	28.64%
2022 FY	365.31 Million SEK	33.19%
2022 Q2	81.29 Million SEK	6.27%
2022 Q1	76.49 Million SEK	-4.97%
2021 Q2	72.26 Million SEK	21.66%
2021 Q4	80.49 Million SEK	29.61%
2021 Q1	59.4 Million SEK	-17.54%
2021 FY	274.27 Million SEK	6.39%
2021 Q3	62.1 Million SEK	-14.06%
2020 Q1	67.73 Million SEK	-14.58%
2020 FY	257.79 Million SEK	-12.19%
2020 Q4	72.04 Million SEK	14.03%
2020 Q3	63.17 Million SEK	15.22%
2020 Q2	54.83 Million SEK	-19.05%
2019 Q1	67.19 Million SEK	2.11%
2019 FY	293.59 Million SEK	14.25%
2019 Q4	79.3 Million SEK	18.35%
2019 Q3	67 Million SEK	-16.34%
2019 Q2	80.09 Million SEK	19.2%
2018 Q4	65.8 Million SEK	-6.1%
2018 FY	256.98 Million SEK	22.42%
2018 Q1	58.65 Million SEK	8.4%
2018 Q2	62.45 Million SEK	6.48%
2018 Q3	70.07 Million SEK	12.2%
2017 Q3	48.8 Million SEK	-3.83%
2017 Q1	56.26 Million SEK	1.46%
2017 Q2	50.74 Million SEK	-9.81%
2017 Q4	54.1 Million SEK	10.87%
2017 FY	209.91 Million SEK	17.88%
2016 Q2	42.49 Million SEK	27.82%
2016 FY	178.07 Million SEK	67.11%
2016 Q4	55.45 Million SEK	18.28%
2016 Q3	46.88 Million SEK	10.35%
2016 Q1	33.24 Million SEK	0.0%
2015 FY	106.56 Million SEK	37.23%
2014 FY	77.65 Million SEK	0.0%

Peer Operating Expenses Comparison of Bonesupport Holding AB (publ)

Name	Operating Expenses	Operating Expenses Difference
AddLife AB (publ)	3.01 Billion SEK	83.048%
Biotage AB (publ)	637 Million SEK	19.791%
Doxa AB (publ)	-259.5 Million SEK	296.89%
Elekta AB (publ)	3.39 Billion SEK	84.928%
iZafe Group AB (publ)	35.92 Million SEK	-1322.094%
Ortivus AB (publ)	48.45 Million SEK	-954.486%
Ortivus AB (publ)	48.45 Million SEK	-954.486%
Q-linea AB (publ)	-43 Thousand SEK	1188309.302%
S2Medical AB (publ)	20.3 Million SEK	-2416.789%
Synsam AB (publ)	3.76 Billion SEK	86.419%